Public Perceptions of Smart Pharmaceutical Packaging in Ireland: Exploring Digital Trust, Medication Adherence, and Adoption Readiness in Chronic Disease Management
| dc.contributor.advisor | Nicola Rice | |
| dc.contributor.author | Anilan, Aabi | |
| dc.date.accessioned | 2026-01-27T11:51:44Z | |
| dc.date.available | 2026-01-27T11:51:44Z | |
| dc.date.issued | 2025 | |
| dc.description.sponsorship | This study demonstrated that although there is still a lack of public awareness regarding Smart Pharmaceutical Packaging (SPP) in Ireland, the technology is generally seen as beneficial for enhancing medication adherence and managing chronic illnesses. While privacy, cost, and usability issues emerged as major obstacles, functional features like reminders, real-time tracking, and connectivity with healthcare providers were found to be the most valued attributes. 113 valid responses from patients, caregivers, medical professionals, and members of the general public were obtained from a quantitative, cross-sectional survey. An online structured questionnaire was used to gather the data, and Microsoft Excel was used for analysis. While crosstabulations and correlation analysis looked at subgroup differences and relationships between digital literacy and adoption readiness, descriptive statistics summarized trends in awareness, perceptions, and behavioral intentions.The findings showed a weak but positive correlation between digital literacy and adoption readiness, indicating that digital competence supports uptake but is not the only determinant, and that adoption was strongly motivated by healthcare provider endorsement. Additionally, subgroup analysis revealed that respondents who were digitally literate and healthcare professionals were more receptive to implementing SPP, whereas some patients with chronic illnesses were more cautious even though they were the group most likely to benefit. The study comes to the conclusion that integrating SPP successfully in Ireland necessitates striking a balance between affordability, inclusivity, public trust, and technological usefulness. Targeted awareness campaigns, robust ethical data protection measures, and stakeholder collaboration to guarantee affordable and user-friendly design are examples of practical recommendations. Although generalizability and causal inference are limited by limitations like non-probability sampling and the cross-sectional design, the results offer insightful information about Irish public readiness for digital health innovation. | |
| dc.identifier.uri | https://go.griffith.ie/handle/123456789/724 | |
| dc.publisher | Innopharma | |
| dc.title | Public Perceptions of Smart Pharmaceutical Packaging in Ireland: Exploring Digital Trust, Medication Adherence, and Adoption Readiness in Chronic Disease Management | |
| dc.type | Thesis |